HIGHLIGHTS
- who: Longfei Wu from the University of Arkansas for Medical Sciences, United States have published the research work: Ischemic post-conditioning in acute ischemic stroke thrombectomy: A phase-I duration escalation study, in the Journal: (JOURNAL) of 10/Dec/2021
- how: The study protocol is designed with reference to the classical 3 + 3 drug trial (Hansen et_al 2014) which is generally used to determine the maximum tolerable dose of a drug in phaseI clinical study.
- future: The maximum tolerable duration obtained in this study will also serve as a starting point for future . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.